¼¼°èÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½ÃÀå
Mobile Cardiac Telemetry Systems
»óǰÄÚµå : 1551555
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 378 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,301,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,905,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 16¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù

2023³â 9¾ï 7,670¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ¼¼°è ½ÃÀåÀº 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È ¿¬Æò±Õ 6.9% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 16¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Çù½ÉÁõ ÀûÀÀÁõÀº CAGR 8.6%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 5¾ï 6,270¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °ü»óµ¿¸Æ Áúȯ ÀûÀÀÁõ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 6.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ¾à 2¾ï 6,610¸¸ ´Þ·¯, Áß±¹Àº CAGR 11.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»ó

¹Ì±¹ÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½ÃÀåÀº 2023³â 2¾ï 6,610¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 3¾ï 4,750¸¸ ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â µ¿¾È 11.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 2.9%¿Í 6.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¿¬Æò±Õ 4.4%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸®À̶õ ¹«¾ùÀ̸ç, ¿Ö Áß¿äÇѰ¡?

¸ð¹ÙÀÏ ½ÉÀå ¿ø°Ý ÃøÁ¤(MCT) ½Ã½ºÅÛÀº ȯÀÚÀÇ ½ÉÀå Ȱµ¿À» ½Ç½Ã°£À¸·Î Áö¼ÓÀûÀ¸·Î °üÂûÇÒ ¼ö ÀÖ´Â ½ÉÀå ¸ð´ÏÅ͸µÀÇ Áß¿äÇÑ ¹ßÀüÀÔ´Ï´Ù. Á¦ÇÑµÈ ±â°£ µ¿¾È µ¥ÀÌÅ͸¦ ±â·ÏÇÏ°í µ¥ÀÌÅÍ ºÐ¼®À» À§ÇØ È¯ÀÚ°¡ Ŭ¸®´ÐÀ¸·Î µ¹¾Æ¿Í¾ß ÇÏ´Â ±âÁ¸ ȦÅÍ ¸ð´ÏÅÍ¿Í ´Þ¸® MCT ½Ã½ºÅÛÀº ¸ð¹ÙÀÏ ³×Æ®¿öÅ©¸¦ ÅëÇØ ECG µ¥ÀÌÅ͸¦ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô Á÷Á¢ Àü¼ÛÇÕ´Ï´Ù. MCT ½Ã½ºÅÛÀÇ ÇÙ½É ¿ä±¸»çÇ×Àº ƯÈ÷ °íÀ§Ç豺 ȯÀÚ³ª Ç¥ÁØ Áø·á½Ç Æò°¡¿¡¼­ Æ÷ÂøÇÒ ¼ö ¾ø´Â ÀϽÃÀûÀÎ ½ÉÀå Áõ»óÀ» °æÇèÇϴ ȯÀڵ鿡°Ô ÀûÇÕÇÑ Àû½Ã¿¡ Á¤È®ÇÏ°í ½Ç¿ëÀûÀÎ µ¥ÀÌÅ͸¦ Á¦°øÇÏ´Â ´É·Â¿¡ ÀÖ½À´Ï´Ù. Áõ»óÀ» °æÇèÇϴ ȯÀڵ鿡°Ô ƯÈ÷ ÀûÇÕÇÕ´Ï´Ù. ÀÌ ±â¼úÀº ½É¹æ¼¼µ¿, ½É½Çºó¸Æ, ±âŸ ºÎÁ¤¸Æ°ú °°ÀÌ ½Å¼ÓÈ÷ ¹ß°ßÇϰí Ä¡·áÇÏÁö ¾ÊÀ¸¸é ½É°¢ÇÑ ¶Ç´Â Ä¡¸íÀûÀÎ °á°ú¸¦ ÃÊ·¡ÇÒ ¼ö ÀÖ´Â ÁúȯÀ» Áø´ÜÇÏ´Â µ¥ ƯÈ÷ Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ, MCT ½Ã½ºÅÛÀº °¡º±°í Âø¿ëÀÌ °¡´ÉÇϸç ħ½ÀÀûÀÌÁö ¾Ê¾Æ ȯÀÚÀÇ ¼øÀÀµµ¿Í Æí¾ÈÇÔÀ» Çâ»ó½ÃÄÑ ÀÏ»ó »ýȰ¿¡ ÁöÀåÀ» ÁÖÁö ¾Ê°í ÀÏ»ó»ýȰÀ» ¿µÀ§ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

±â¼úÀº MCT ½Ã½ºÅÛÀÇ È¿°ú¸¦ ¾î¶»°Ô Çâ»ó½Ãų ¼ö Àִ°¡?

¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸®À» µÞ¹ÞħÇÏ´Â ±â¼úÀº ÷´Ü ¹ÙÀÌ¿À¼¾¼­, ¸ð¹ÙÀÏ ¿¬°á, Ŭ¶ó¿ìµå ±â¹Ý ºÐ¼®À» °íµµ·Î À¶ÇÕÇÑ °ÍÀ¸·Î, MCT ÀåÄ¡¿¡´Â ÀϹÝÀûÀ¸·Î ½ÉÀåÀÇ Àü±âÀû Ȱµ¿À» Æ÷ÂøÇÏ´Â Àü±Ø, ÀÌ µ¥ÀÌÅ͸¦ ½Ç½Ã°£À¸·Î Áß¾Ó ¸ð´ÏÅ͸µ ½ºÅ×À̼ÇÀ¸·Î Àü¼ÛÇÏ´Â ¼Û½Å±â, ±×¸®°í Á¤º¸¸¦ ºÐ¼®ÇÏ´Â ¼ÒÇÁÆ®¿þ¾î°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ½Ç½Ã°£À¸·Î Áß¾Ó ¸ð´ÏÅ͸µ ½ºÅ×À̼ÇÀ¸·Î Àü¼ÛÇÏ´Â ¼Û½Å±â, ÀÌ»ó À¯¹«¸¦ ºÐ¼®ÇÏ´Â ¼ÒÇÁÆ®¿þ¾î°¡ Æ÷ÇԵ˴ϴÙ. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ ÅëÇÕÀº MCT ½Ã½ºÅÛÀÇ È¿À²¼ºÀ» ´õ¿í ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾Ë°í¸®ÁòÀº ºÒ±ÔÄ¢ÇÑ ½ÉÀå ¹Úµ¿ ÆÐÅÏÀ» ½Å¼ÓÇÏ°Ô ½Äº°ÇÒ ¼ö ÀÖ¾î ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô Á¶±â °æº¸ ½Ã½ºÅÛÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ´ë±Ô¸ð µ¥ÀÌÅÍ ¼¼Æ®¸¦ Àå±â°£ ÀúÀåÇÏ°í ºÐ¼®ÇÒ ¼ö ÀÖ´Â ´É·ÂÀº Ãß¼¼¿Í ÆÐÅÏÀ» ½Äº°ÇÏ°í ´õ ¸¹Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÓ»óÀû ÆÇ´ÜÀ» ³»¸± ¼ö ÀÖ¾î ȯÀÚ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ Àü¼ÛÀÇ ¾ÈÁ¤¼º°ú ÃֽЏð¹ÙÀÏ ³×Æ®¿öÅ©ÀÇ ³·Àº Áö¿¬ ½Ã°£À¸·Î ÀÎÇØ ½ÉÀå ±â´ÉÀÇ ¹Ì¼¼ÇÑ ÆíÂ÷µµ È®½ÇÇÏ°Ô °¨ÁöÇϰí ÀÇ·á Àü¹®°¡¿¡°Ô ½Å¼ÓÇÏ°Ô Àü´ÞÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

MCT ½Ã½ºÅÛ µµÀÔ¿¡ ÀÖ¾î ¼ÒºñÀÚ ÇൿÀº ¾î¶² ¿ªÇÒÀ» Çϴ°¡?

¼ÒºñÀÚ Çൿ°ú ȯÀÚ Âü¿©´Â ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸®ÀÇ º¸±Þ¿¡ ÀÖ¾î Á¡Á¡ ´õ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ȯÀÚ°¡ ÀÚ½ÅÀÇ °Ç°­¿¡ ´ëÇØ º¸´Ù Àû±ØÀûÀ¸·Î Á¤º¸¸¦ ¾ò°Ô µÇ¸é¼­ Æí¸®¼º, Á¤È®¼º, ¾È½ÉÇÒ ¼ö ÀÖ´Â ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, Äڷγª19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ °¡¼ÓÈ­µÇ°í ÀÖ´Â ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ÀÇ·á ¼­ºñ½º·ÎÀÇ ÀüȯÀº MCT¿Í °°Àº ±â¼úÀÇ Á߿伺À» ´õ¿í ºÎ°¢½Ã۰í ÀÖ½À´Ï´Ù. ±â¼úÀÇ Á߿伺À» ´õ¿í ºÎ°¢½Ã۰í ÀÖ½À´Ï´Ù. ȯÀÚµéÀº ÀÌÁ¦ ¿þ¾î·¯ºí ±â±â¿¡ Àͼ÷ÇØÁ³°í, Àü¹ÝÀûÀÎ Ä¡·á Àü·«ÀÇ ÀÏȯÀ¸·Î ½Ç½Ã°£ °Ç°­ ¸ð´ÏÅ͸µÀ» ±â´ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ MCT ½Ã½ºÅÛÀÇ »ç¿ë ÆíÀǼº°ú ºñħ½À¼ºÀº ±âÁ¸ ¸ð´ÏÅ͸µ ¹æ¹ýÀ» ½È¾îÇÏ´Â °í·É ȯÀÚµéÀ» Æ÷ÇÔÇÑ ´õ ¸¹Àº ȯÀڵ鿡°Ô ¾îÇÊÇϰí ÀÖ½À´Ï´Ù. ½º¸¶Æ®Æù ¹× ±âŸ °³ÀÎ¿ë ±â±â¿Í ¿øÈ°ÇÏ°Ô ÅëÇÕÇÒ ¼ö ÀÖ´Ù´Â Á¡µµ MCT ½Ã½ºÅÛÀÇ ¸Å·Â¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ȯÀÚµéÀº ÀÚ½ÅÀÇ °Ç°­ ÁöÇ¥¸¦ ½±°Ô ÃßÀûÇϰí ÀÇ·áÁø°ú µ¥ÀÌÅ͸¦ °øÀ¯ÇÒ ¼ö ÀÖ¾î º¸´Ù °³ÀÎÈ­µÈ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù.

MCT ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¸ð¹ÙÀÏ ½ÉÀå ¿ø°Ý ÃøÁ¤(Mobile Cardiac Telemetry) ½ÃÀåÀÇ ¼ºÀåÀº ÇコÄɾî¿Í ±â¼úÀÇ ÁøÈ­¸¦ ¹Ý¿µÇÏ´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â Àü ¼¼°èÀûÀ¸·Î ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ƯÈ÷ ºÎÁ¤¸Æ ¹× ±âŸ ½ÉÀå ÁúȯÀÇ À§ÇèÀÌ ³ôÀº °í·ÉÈ­ »çȸ¿¡¼­ Áõ°¡¸¦ µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñ¸¸, ´ç´¢º´, °íÇ÷¾Ð µî ½ÉÀ庴°ú ¹ÐÁ¢ÇÑ °ü·ÃÀÌ ÀÖ´Â »ýȰ½À°üº´ÀÇ ¹ßº´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó MCT¿Í °°Àº Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, 4G ¹× 5G ³×Æ®¿öÅ©ÀÇ È®ÀåÀ» Æ÷ÇÔÇÑ ¸ð¹ÙÀÏ ±â¼úÀÇ ¹ßÀüÀº MCT ½Ã½ºÅÛÀÇ ½Ç½Ã°£ ±â´É¿¡ ÇʼöÀûÀÎ ´õ ºü¸£°í ½Å·ÚÇÒ ¼ö ÀÖ´Â MCT ½Ã½ºÅÛÀÇ ½Ç½Ã°£ ±â´É¿¡ ÇʼöÀûÀÎ º¸´Ù ºü¸£°í ¾ÈÁ¤ÀûÀÎ µ¥ÀÌÅÍ Àü¼ÛÀ» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿¹¹æ ÀÇ·á¿Í Á¶±â Áø´Ü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÇ·áÁø°ú ȯÀÚ ¸ðµÎ MCT ½Ã½ºÅÛÀ» ½ÉÀå Ä¡·áÀÇ Ç¥ÁØÀ¸·Î äÅÃÇϰí ÀÖ½À´Ï´Ù. ÀϺΠÁö¿ªÀÇ ±ÔÁ¦ Áö¿ø°ú À¯¸®ÇÑ »óȯ Á¤Ã¥Àº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí MCT ½Ã½ºÅÛÀ» ´õ ¸¹Àº ȯÀÚµéÀÌ ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, º¸´Ù Á¤±³ÇÏ°í »ç¿ëÇϱ⠽¬¿î ±â±âÀÇ Ãâ½Ã·Î »õ·Î¿î »ç¿ëÀÚ°¡ °è¼Ó Áõ°¡Çϰí ÀÖ¾î ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½ÃÀåÀº ÇâÈÄ ¸î ³âµ¿¾È Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÃÑ 42°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Mobile Cardiac Telemetry Systems Market to Reach US$1.6 Billion by 2030

The global market for Mobile Cardiac Telemetry Systems estimated at US$976.7 Million in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Angina Pectoris Indication, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$562.7 Million by the end of the analysis period. Growth in the Coronary Artery Diseases Indication segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$266.1 Million While China is Forecast to Grow at 11.3% CAGR

The Mobile Cardiac Telemetry Systems market in the U.S. is estimated at US$266.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$347.5 Million by the year 2030 trailing a CAGR of 11.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Mobile Cardiac Telemetry Systems Market - Key Trends and Drivers Summarized

What Are Mobile Cardiac Telemetry Systems and Why Are They Critical?

Mobile Cardiac Telemetry (MCT) systems represent a significant advancement in cardiac monitoring, providing real-time, continuous observation of a patient's heart activity. Unlike traditional Holter monitors, which record data for a limited period and require the patient to return to the clinic for data analysis, MCT systems transmit ECG data directly to healthcare providers via mobile networks. This allows for immediate detection and intervention in cases of arrhythmias or other cardiac events. The critical need for MCT systems lies in their ability to provide timely, accurate, and actionable data, especially for high-risk patients or those experiencing transient cardiac symptoms that might not be captured during a standard in-office evaluation. This technology is particularly crucial for diagnosing conditions like atrial fibrillation, ventricular tachycardia, and other arrhythmias, which can have serious or fatal outcomes if not promptly identified and treated. Additionally, MCT systems enhance patient compliance and comfort, as they are lightweight, wearable, and minimally invasive, enabling patients to go about their daily activities without interruption.

How Does Technology Elevate The Effectiveness of MCT Systems?

The technology behind Mobile Cardiac Telemetry systems is a sophisticated blend of advanced biosensors, mobile connectivity, and cloud-based analytics. MCT devices typically include electrodes that capture the heart's electrical activity, a transmitter that sends this data in real-time to a central monitoring station, and software that analyzes the information for any abnormalities. The integration of artificial intelligence (AI) and machine learning algorithms has further elevated the effectiveness of MCT systems. These algorithms can quickly identify irregular patterns in heartbeats, providing an early warning system for healthcare providers. Furthermore, the ability to store and analyze large datasets over time allows for better patient outcomes, as trends and patterns can be identified, leading to more informed clinical decisions. The reliability of data transmission and the low latency of modern mobile networks ensure that even the slightest deviation in heart function is detected and communicated to medical professionals promptly.

What Role Does Consumer Behavior Play in The Adoption of MCT Systems?

Consumer behavior and patient engagement are playing increasingly vital roles in the widespread adoption of Mobile Cardiac Telemetry systems. As patients become more informed and proactive about their health, there is a growing demand for monitoring solutions that offer convenience, accuracy, and peace of mind. The shift toward telemedicine and remote healthcare services, accelerated by the COVID-19 pandemic, has further highlighted the importance of technologies like MCT. Patients are now more comfortable with wearable devices and expect real-time health monitoring as part of their overall care strategy. Additionally, the ease of use and non-invasive nature of MCT systems appeal to a broader demographic, including elderly patients who might be averse to traditional monitoring methods. The ability of these systems to integrate seamlessly with smartphones and other personal devices also contributes to their appeal, as patients can easily track their own health metrics and share data with their healthcare providers, leading to more personalized care.

What Factors Are Driving The Growth of The MCT Market?

The growth in the Mobile Cardiac Telemetry market is driven by several factors that reflect the evolving landscape of healthcare and technology. One of the primary drivers is the increasing prevalence of cardiovascular diseases globally, particularly in aging populations where the risk of arrhythmias and other heart conditions is higher. Additionally, the rising incidence of lifestyle-related conditions, such as obesity, diabetes, and hypertension, which are closely linked to heart disease, has amplified the need for continuous monitoring solutions like MCT. Advances in mobile technology, including the expansion of 4G and 5G networks, have also played a crucial role by enabling faster and more reliable data transmission, which is essential for the real-time capabilities of MCT systems. Moreover, the growing focus on preventive healthcare and early diagnosis is pushing both healthcare providers and patients toward adopting MCT systems as a standard part of cardiac care. Regulatory support and favorable reimbursement policies in several regions have further bolstered market growth, making these systems more accessible to a wider patient base. Lastly, the ongoing development of more sophisticated and user-friendly devices continues to attract new users, ensuring that the market for Mobile Cardiac Telemetry systems will expand in the coming years.

Select Competitors (Total 42 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â